ASH Annual Meeting and Exposition leaves the oncology community buzzing over a series of late-breaking presentations that experts are calling 'unprecedented.' Major pharmaceutical developers such as ...

Panelists discuss how the treatment landscape has evolved from limited options to include hypomethylating agents and venetoclax combinations, with emerging oral formulations promising greater ...

In the high-velocity markets of New York—from the financial corridors of Manhattan to the burgeoning tech hubs in ...

For Geneva International Insurance, 2025 was a year of intentional progress, not a sprint for change, but a deliberate strengthening of the foundations that sustain long-term trust. In an environment ...